One study analyzed next-generation sequencing data from 220 CTCL patients and found the NF1 gene to serve as one of several genetic drivers in these tumors, due it its amplification of the MAPK signaling pathway [90]. Here, NF1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.